Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 1, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
On October 31, 2006, Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("the GSK Trust"), transferred 3,100 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on November 1, 2006.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It notes that the GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries. Consequently, three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold an interest in the shares held in the GSK Trust in the same manner as other employees. The transaction was notified in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- 3,100 Ordinary Shares were transferred from the GSK Trust to employee plan participants on October 31, 2006.
- Three directors have an indirect interest in the GSK Trust shares alongside other employees.
- This filing contains no financial results or operational updates for the period.